1. Describe the latest treatments of breast cancer.
2. Identify the latest information on clinical relevance of biomarkers for breast cancer.
3. Describe recent changes with regards to HER2-directed therapy in breast cancer
4. Contextualize these HER2-directed therapy updates within current practice
5. Explain the use of immunotherapy in triple negative breast cancer
- 1.00 ACPE Contact Hours
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC Contact Hours
- 1.00 University of Wisconsin–Madison Continuing Education Hours